GDUFA Research Outcomes
Injectable Products
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to injectable generic drug products.
-
Regulating Generic Nanotechnology Drug Products: Guidance and Standards
Jiang, Wenlei
-
Advanced Analytical Methods to Characterize Liposome Drug Products
Jiang, Wenlei
-
Regulatory Research in Nanomedicine Drug Products
Jiang, Wenlei
-
US FDA Perspectives for Bioequivalence (BE) Evaluation of Liposome Drug Products
Jiang, Wenlei
-
Excipients in Parenteral Drug Products
Jiang, Wenlei
-
Characterizations of Nanomaterials
Jiang,Wenlei
-
Equivalence Testing of Complex Particle Size Distribution Profiles Based on Earth Mover’s Distance
Hu, Meng
-
Evaluation Of Biomarkers In Healthy Subjects Treated With Generic And Reference Sodium Ferric Gluconate
Alloush, Jenna; Jones, Jace; Polli, James; Michel, Sarah; Kane, Maureen
-
Mechanistic Modeling of Complex Injectables: Recommendations to Navigate Regulatory Challenges
Andre, Kris
-
Doxorubicin HCl Release from Liposomal Doxorubicin Formulations – Autonomous Capillary Electrophoretic (CE) In Vitro Release Test (IVRT) Method
Jayaraj, Savithra; Jiang, Wenlei; Mudalige, Thilak